Applied Dna Sciences Inc (NASDAQ:BNBX) Sees Significant Decrease in Short Interest

Applied Dna Sciences Inc (NASDAQ:BNBX) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 231,818 shares, a decline of 64.2% from the April 15th total of 647,929 shares. Based on an average daily trading volume, of 3,279,719 shares, the short-interest ratio is currently 0.1 days. Approximately 4.4% of the company’s shares are sold short.

Applied Dna Sciences Stock Down 4.2%

Shares of Applied Dna Sciences stock traded down $0.02 on Thursday, reaching $0.46. 7,058 shares of the company’s stock were exchanged, compared to its average volume of 634,195. The firm has a market cap of $2.61 million, a P/E ratio of 0.00 and a beta of 0.58. Applied Dna Sciences has a 52 week low of $0.45 and a 52 week high of $12.75. The business has a 50-day moving average price of $0.63.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Applied Dna Sciences in a research note on Friday, April 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.